Dual Endothelin Receptor Type A/Bradykinin B1 Receptor Antagonists (University of Montreal)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDual Endothelin Receptor Type A/Bradykinin B1 Receptor Antagonists (University of Montreal)
Drug Alias NameDual ETA/BKB1 Antagonists (University of Montreal)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBradykinin B1 receptor antagonistsEndothelin receptor type A antagonists
TargetsEndothelin receptor type ABradykinin B1 receptor
Therapy Area/IndicationsPainOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversite De Montreal
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversite De MontrealUnivalor
Active IndicationsN/A
Inactive IndicationsPainOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A